Micron: The Illusion of a Low P/E Ratio Amidst Market Volatility
Finance

Micron: The Illusion of a Low P/E Ratio Amidst Market Volatility

authorBy Mariana Mazzucato
DateJul 12, 2026
Read time2 min

After an astonishing surge in value, Micron (MU) has achieved a market capitalization exceeding $1.1 trillion. This remarkable growth is largely attributed to a temporary supply-demand imbalance within the global DRAM and NAND sectors. Projections indicate the company's earnings per share could reach a peak of $163.85 by the fiscal year 2028. Recent reports for the third quarter of fiscal year 2026 reveal a substantial 67% increase in DRAM revenues quarter-over-quarter, driven by a surge in average selling prices, even as bit shipment volumes held steady. Looking ahead, Micron is set to embark on a massive investment program, earmarking over $250 billion for operations within the United States through 2035.

The Shifting Landscape of Memory Chip Manufacturing: Micron's Position and Future Outlook

In a dynamic shift within the semiconductor industry, Micron Technology, headquartered in Silicon Valley, California, has witnessed an extraordinary period of growth. Following a detailed assessment of the NAND memory sector, particularly in comparison to competitors, a closer examination of Micron's strategic positioning in both NAND and DRAM markets reveals significant insights. The company's impressive valuation surge to over a trillion dollars underscores the current market frenzy for memory solutions, driven by unprecedented demand and prevailing supply chain constraints. This unique market environment is enabling Micron to achieve substantial revenue increases, especially within its DRAM division, where average selling prices have soared.

Amidst this backdrop, key players such as SK Hynix are also preparing for massive expansion, with plans to double their overall production capacity in the coming five years. This impending surge in supply from major manufacturers, combined with Micron's own substantial investments in the U.S., raises crucial questions about the long-term market equilibrium. The potential for a significant increase in memory chip output coinciding with a possible deceleration in demand presents a complex challenge. The sustainability of hyperscalers' infrastructure build-out, which currently relies heavily on these memory components, will be tested under evolving market conditions.

This scenario prompts an important reflection: while the current momentum appears robust, the industry must prepare for the potential ramifications of increased production meeting a fluctuating demand landscape. The cyclical nature of the semiconductor market, characterized by periods of boom and bust, suggests a need for cautious optimism. The rapid expansion of manufacturing capabilities, though indicative of strong current demand, could lead to an oversupply in the future, impacting pricing and profitability. It is essential for industry leaders and investors to carefully monitor these dynamics to navigate the intricate path ahead successfully.

More Articles
Finance
STMicroelectronics: Overvalued, Downgraded to 'HOLD'
STMicroelectronics has experienced a remarkable 190% return on investment, primarily fueled by a surge in AI demand and its initial undervaluation. However, its current valuation, with a trailing P/E ratio exceeding 400x and a forward P/E above 40x, significantly surpasses both its fundamental performance and peer averages. This has prompted a downgrade to 'HOLD' due to concerns over its high valuation, weakening margin normalization, and increased risks associated with its exposure to the automotive and industrial sectors.
By Michele FerreroJul 12, 2026
Finance
Assessing Meta Platforms as a Long-Term Investment
This article explores whether Meta Platforms is a viable long-term investment by analyzing its financial health, AI investments, and market performance. It delves into Meta's capital allocation, profitability, and AI monetization strategies, encouraging investors to look beyond daily stock fluctuations. The piece also examines past spending on the metaverse versus current AI initiatives and provides an analyst's rating, offering a comprehensive view for potential long-term investors.
By Strive MasiyiwaJul 12, 2026
Finance
BridgeBio Pharma: A Strong Buy for Biotech Innovation and Market Expansion
BridgeBio Pharma continues to be a top recommendation, driven by successful regulatory approvals, a robust development pipeline, and strong commercial performance of its key therapeutic, Attruby. The company is advancing multiple New Drug Applications and securing its financial future with strategic funding to support ongoing research and market penetration.
By Fareed ZakariaJul 12, 2026
Finance
Missed Opportunities: Why Retirees Overlook Roth IRA Conversions
Many retirees fail to utilize an 11-year window between retirement and Required Minimum Distributions to convert traditional IRA funds to Roth IRAs at lower tax rates. Despite the clear financial advantages, the average retiree converts nothing, primarily due to the immediate out-of-pocket tax payment required and declining personal savings rates. Financial experts recommend strategic, phased conversions to maximize tax benefits.
By Lisa JingJul 12, 2026
Finance
Palantir's Path to Prosperity: The $42 Billion Revenue Challenge
Palantir (PLTR) must achieve a staggering $42 billion in annual revenue and a 61% Free Cash Flow margin by 2030 to validate its current stock valuation. While recent growth and improved margins are encouraging, the company's reliance on intensive integration and human capital may limit its scalability. Currently, the stock is in a technical downtrend, requiring a break above the 200-day Simple Moving Average for a bullish reversal. Given these factors, I am maintaining a 'Hold' rating on Palantir, awaiting its Q2 earnings report and a clear trend reversal before re-evaluating its investment potential.
By Robert KiyosakiJul 12, 2026